Nu Skin Enterprises traded at $7.11 this Thursday March 12th, decreasing $0.20 or 2.74 percent since the previous trading session. Looking back, over the last four weeks, Nu Skin Enterprises lost 14.95 percent. Over the last 12 months, its price fell by 9.54 percent. Looking ahead, we forecast Nu Skin Enterprises to be priced at 7.43 by the end of this quarter and at 6.78 in one year, according to Trading Economics global macro models projections and analysts expectations.
Nu Skin Enterprises, Inc. is a holding company. The Company through Nu Skin, a global direct selling company is engaged in developing and distributing personal care products and wellness products that are sold worldwide under the Nu Skin, Pharmanex and ageLOC brands. Nu Skin offers beauty and personal care products, which includes 180 System, AP 24, Body, DR. Dana, Epoch, Nu Colour, Nutricentials, Tri-Phasic White, Tru Face and Sunright. Pharmanex offers nutritional products, including ageLOC R2, ageLOC Vitality, ageLOC Youth, g3, LifePak, TR90 and S3 Scanner. Its ageLOC provides anti-aging products, which includes Facial Spa, Me, LumiSpa, TFEU and Transformation products. The Company operates through nine segments, which consists of seven geographic Nu Skin segments, including Mainland China, South Korea, Southeast Asia, Americas/Pacific, Hong Kong/Taiwan, Europe, Middle East and Africa (EMEA), and Japan. Its segments also include Manufacturing segment and Grow Tech segment.